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1. Introduction 
Although both cyclic nucleotides, adenosine and 
guanosine 3':5'-cyclic monophosphates (cyclic AMP 
and cyclic GMP, respectively) occur in high concen- 
trations in nervous tissue [1 ], little is known about 
their functions. The complexity of the structure of 
nervous tissue makes the interpretation difficult of 
data obtained from biochemical nd pharmacological 
experiments with this material. Clonal cell lines 
derived from nervous tissue can serve as simple model 
systems, ince they retain differentiated functions of 
the nervous ystem. Thus, neuroblastoma × glioma 
hybrid cells can be induced to extend neurite-like 
processes [2,3], they have high activities of choline 
acetyltransferase [2] and contain clear and dense 
core vesicles [4]. Their membranes are excitable by 
depolarizing current [2] or by the neurohormones 
acetylcholine [2] and noradrenaline [5]. In the 
hybrid and neuroblastoma ceils the intracellular level 
of cyclic AMP strongly increases in response to 
prostaglandin El [6]. This action of prostaglandin E1
is potently obviated by noradrenaline [5], acetyl- 
choline [7] and opiates [8-10]. The effect of 
opiates is probably mediated by cyclic GMP [11 ]. 
In the present communication we report hat in 
the hybrid and neuroblastoma cells low concentra- 
tions of the cholinergic agonists carbamoylcholine 
(Carb), tetramethylammonium (TMA) and pilocar- 
pine (Pil) increase the intracellular concentration f 
cyclic GMP, while high concentrations of acetyl- 
choline may slightly elevate the level of cyclic AMP. 
The responses to Carb and TMA are more pronounced 
in the presence of high (154 mM) than of low (5 mM) 
concentrations of Na +. The effects of Pil at high Na ÷ 
are even inverse to those at low Na ÷ concentration. 
Thus, while 1/aM Pil lowers the level of cyclic GMP 
and elevates that of cyclic AMP in the former case, it 
does the reverse in the latter case. 
2. Materials and methods 
Acetylcholine chloride was purchased from E. 
Merck, carbamoylcholine chloride from Fluka, tetra- 
methylammoniumhydroxide-5 H20 and 
pilocarpine-HC1 from Sigma. 
Neuroblastoma × glioma hybrid line 108CC15 was 
obtained by fusion of line N18TG2 and rat glioma 
line C6-BU-1 [2]. The clonal ines N4TG3, N18TG2, 
NS2OY and N1E-115 were derived from mouse neuro- 
blastoma C-1300 [12]. N4TG3 [13] and N18TG2 
[14] are 6-thioguanine r sistant mutants of N4 and 
N18, respectively. Since NS2OY contains choline 
acetyltransferase, N1 E-115 tyrosine hydroxylase and 
N4 and N18 neither enzyme, these lines were classi- 
fied as cholinergic, adrenergic and 'inactive' cell lines, 
respectively [12]. 
The cells were cultured in plastic dishes 85 mm in 
diameter [15] and subcultured by using isotonic 
solutions [16] of 0.005 % trypsin (crystallized twice, 
Boehringer/Mannheim). 
One hour before the experimental incubation, the 
growth medium was replaced by 5 ml of incubation 
74 North-Holland Publishing Company - Amsterdam 
Volume 59, number 1 FEBS LETTERS November 1975 
medium [17]. Two kinds of incubation media were 
employed containing either 154 or 5 mM Na ÷. The 
osmolality of the latter was adjusted to 320 mosM by 
the addition of choline chloride. The cholinergic 
agents were added as described [8]. After the extrac- 
tion, separation and purification, cyclic GMP [11 ] 
and cyclic AMP [8] were determined by protein bind- 
ing assays. 
3. Results 
Exposure of the hybrid cells to Carb causes a
strong and rapid increase in the intracellular level of 
cyclic GMP (fig. 1, curves I and II). The response is
highest after only 1 min of incubation (fig.lA). With 
prolonged exposure to Carb (fig. 1B and C) the level 
of cyclic GMP falls progressively. The maximal effect 
of the cholinergic agent is seen at already 0.1 nM 
(fig. 1 A, B and C). A further increase in concentration 
reduces the level of cyclic GMP found. Thus, after 
10 rain exposure to 1/aM Carb the intracellular con- 
centration of cyclic GMP is no longer different from 
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Fig.1. Influence of the concentration f Carb on the levels of 
cyclic GMP (solid line) and cyclic AMP (broken line) in clonal 
hybrid line 108CC15 during various times of incubation at 
high (filled symbols) and at low (open symbols) concentra- 
tions of Na +. Mean values of 3 replica plates -+S.D. 1.2 X 106 
viable cells and 1.3 mg protein per plate, viability 94%, 
passage number 10. The cells were incubated at 37 ° with 
Carb for I min (A), 5 min (B) and 10 rain (C). Incubations 
for 1 min were performed by immersing the plates into a 
water bath, those at 5 and 10 rain were carried out in a cell 
incubator. 
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Fig.2. The effect of the eholinergic agonists Carb (circles), 
TMA (squares) and Pil (triangles) on the lev.eis of cyclic GMP 
(closed symbols and solid line) and cyclic AMP (open symbols 
and broken line) at high (A) and low (B) concentration f 
Na ÷. Incubation time was 5 min. 1.4 X 106 viable cells and 
1.5 mg protein per replica plate, viability 93%, passage 
number 12. 
that of the controls (fig.1 C, curve I). At high concen- 
trations of Na + the concentration f cyclic GMP is 
raised to higher values than at low concentrations of 
Na + (fig. 1, curves I and II). In all cases the changes of 
the levels of cyclic AMP (fig.l, curves III and IV) are 
inversely related to those of cyclic GMP. Results, not 
presented here, with acetylcholine asstimulant, were 
qualitatively similar to those obtained with Carb. 
In order to obtain an indication whether nicotinic 
or muscarinic holinergic receptors were involved in 
these effects, the hybrid cells were exposed for 5 min 
to 3 types of cholinergic agonists [18]. At concen- 
trations up to 0.1 nM all 3 agents cause an increase of 
the level of cyclic GMP and a concomitant decrease 
of the level of cyclic AMP (fig.2A, curves I to III), if 
high concentrations of Na + are present. The maximal 
effect of Carb (fig.2A, curve I) is somewhat higher 
than that of TMA (fig.2A, curve II), while that of Pil 
(fig.2A, curve III) is much less pronounced. As the 
concentrations are raised from O. 1 nM to 10/aM, the 
level of cyclic GMP approaches a plateau at a reduced 
value. For Carb (fig.2A, curve II) this value is well 
above that of the control (absence of drug), but for 
the other 2 agents (fig.2A, curves II and III) it is only 
a fraction of that of the control. Again, the levels of 
cyclic AMP (fig.2A, curves III to VI) change inversely 
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to those of cyclic GMP. It is specially striking that at 
high concentrations TMA (fig.2A, curve V) and Pil 
(fig.2A, curve VI) elevate the levels of cyclic AMP 
above base line. At low concentration f Na+ (fig.2B), 
the maximal level of cyclic GMP reached in the 
presence of Carb (fig.2B, curve I) or TMA (fig.2B, 
curve II) is markedly reduced, if compared to the 
results obtained at high Na+ concentration (fig.2A). 
Otherwise the curves (fig.2B, curves I, II, IV and V) 
are qualitatively similar to the corresponding ones in 
fig.2A. Lowering the Na+ concentration exerts a 
remarkable effect on the response voked by Pil. At 
concentrations upto 0.1 nM Pil depresses the level of 
cyclic GMP (fig.2B, curve III) while it slightly elevates 
that of cyclic AMP (fig.2B, curve VI), and at concen- 
trations further up to 10/aM it does just the reverse. 
Thus, if the ligand of the cholinergic receptor is Pil, 
it appears that the change in the Na+ concentration 
caused adenylate and guanylate cyclases to exchange 
their roles. 
The response to the cholinergic agents of 4 neuro- 
blastoma lines is very similar to that of the neuro- 
blastoma × glioma hybrid clone 108CC15. This 
implies that the 4 lines show no striking differences 
between them. As shown in fig.3 (A,C,E,G), at high 
Na ÷ concentration a maximal increase of the level of 
cyclic GMP is reached in the range of 0.1 to 1 nM 
agonist. As the concentrations of the cholinergic 
agents rise further, the elevations of cyclic GMP levels 
fade away and eventually are turned into depressions. 
Again, considerable elevations are seen only in the 
presence of Carb or TMA (fig.3A,C,E,G, curves I and 
II), whereas Pil causes only a slight increase at low 
concentrations, but the strongest depression at 10/aM 
concentration (fig.3A,C,E,G, curves III). At low Na ÷ 
concentration the reduced response to Carb or TMA 
is seen again (fig.3B,D,F,H, curves I and II). As 
described for the hybrid cells, at low Na ÷ concentra- 
tion Pil shows a concentration dependency of its 
effects which is inverse to that of the other 2 agents. 
Low concentrations lower and high concentrations 
elevate the concentration f cyclic GMP (fig.3B,D,F, 
H, curves III). 
4. Discussion 
Eight interrelated aspects of the data shall be dis- 
cussed. The first, the elevation of the level of cyclic 
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Fig.3. The effect of cholinergie agonists Carb (circles), TMA 
(squares) and Pil (triangles) on the production of cyclic GMP 
in mouse neuroblastoma lines N4TG3 (A, B), N18TG2 
(C, D), NS2OY (E, F) and N1E-115 (G, H) in the presence of 
high (A, C, E, G) and low Na* concentration (B, D, F, H). The 
numbers of viable cells (in millions per plate), viabllities and 
passage numbers, respectively, were: N4TG3, 1.7, 93%, 20; 
N18TG2: 1.3, 90%, 15; NS2OY: 1.2, 96%, 10; N1E-115: 1.4, 
94%, 9. Time of incubation was 5 min. 
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GMP in the hybrid cells, had been expected, since 
cholinergic agonists attenuate he increase of the level 
of cyclic AMP caused by prostaglandin El [7] or 
adenosine [21]. Such action of prostaglandin El is 
also obviated by noradrenaline [5] and morphine 
[8,19], 2 agents known to increase the intraceUular 
levels of cyclic GMP [11,20] in the hybrids. Choliner- 
gic agonists increase the level of cyclic GMP in heart 
[22,23], brain [23-25], liver and thyroid [26], 
ileum [25], vas deferens [27], fat cells [28] and 
lung [29] and partially prevent the increase of the 
concentration f cyclic AMP by isoproterenol r
glucagon in heart [30] or by adrenaline in uterus 
[31]. 
In the hybrid cells, the action of the eholinergic 
agents is already half maximal at the very low con- 
centration of 10 pM. On the other hand, the concen- 
tration of acetylcholine causing 50% inhibition of the 
effect of prostaglandin E1 is 0.1/aM. This discrepancy 
is the second aspect of these data. It may be due to 
the elevation of the level of cyclic AMP in the 
presence of prostaglandin E~. Work is under way to 
elucidate this phenomenon. 
The third aspect is that at concentrations above 
0.1 to 1 nM the elevation of the level of cyclic GMP 
by the cholinergic agonists becomes progressively 
smaller. One explanation could be that in the cell 
surface there exist 2 types of receptors with markedly 
different binding constants for cholinergic agonists. 
If a ligand bound to the high affinity receptor, an 
activation of guanylate cyclase would ensue; if it 
occupied the low affinity receptor, activation of 
adenylate cyclase, an increase in the level of cyclic 
AMP and a decrease in the rate of formation of cyclic 
GMP would be the consequence, b~uother, perhaps 
simpler explanation is derived from the observation 
that high doses of acetylcholine desensitize the mem- 
branes of the hybrid cells [2]. Earlier studies of the 
desensitization phenomenon in other systems led to 
the conclusion that the nicotinic acetylcholine r cep- 
tor can exist in 2 different states [32]. Binding of an 
agonist by the 'active' receptor causes a depolarization 
of the membrane, while binding to the 'desensitized' 
does not. Thus, in the hybrid cells the stimulation of 
the formation of cyclic GMP by low concentrations 
of the cholinergic agonists may be mediated by the 
'active' form of the receptor. Increasing concentra- 
tions of the agonists will allow more and more recep- 
tors to switch to the 'desensitized' form [32], and 
thus, with the decrease in the population of 'active' 
receptors also the rate of formation of cyclic GMP 
drops. Ligand binding studies using membrane frag- 
ments from the electric organ of Torpedo [33] or 
from intestinal smooth muscle of guinea pig [34] 
support he view of the existence of the receptor in 
2 different states. Also in other systems biological 
responses (including the elevation of the level of 
cyclic GMP) that occur at low concentrations of 
cholinergic agonists are not observed at high concen- 
trations [28,35]. 
Another, the fourth aspect of this work is the 
transient response inspite of the continuous presence 
of the cholinergic agonist. This unexplained effect, 
which has also been observed in other systems [20, 
22,23,28,36] is the object of further studies in our 
laboratory. 
The fifth aspect is related to the previous one and 
deals with the increase of the level of cyclic AMP, at 
high concentrations of the agonists (cf. fig.2B). In the 
hypothesis just mentioned this would mean that occu- 
pation of the 'desensitized' form of the receptor is 
followed by enhanced adenylate cyclase activity. 
Thus, the striking inverse relationship n the levels of 
cyclic AMP and cyclic GMP would find a partial 
explanation. In those cases, in which the level of 
cyclic GMP is depressed below baseline while that of 
cyclic AMP rises well above the controls, an addition- 
al mechanism ust be at work. Probably the elevated 
level of cyclic AMP either causes an enhanced rate of 
degradation ra decreased rate of synthesis of cyclic 
GMP. Qualitatively analogous to the responses evoked 
by cholinergic agonists were those caused by opiates: 
elevation of cyclic GMP at low, of cyclic AMP levels 
at high concentrations and inverse changes of the 
levels of the 2 cyclic nucleotides [11 ]. 
The elevation of the level of cyclic AMP at high 
agonist concentrations is pecially pronounced if the 
Na ÷ concentration is low. This takes us to the sixth 
aspect, the influence of Na+ ions. At low concentra- 
tions of both Na + and agonist, the elevation of cyclic 
GMP is less than in the presence of high Na ÷ concen- 
tration. It appears as if at the low concentration f 
Na ÷ the 'desensitized' state of the cholinergic recep- 
tor was more populated than at high Na ÷ concentra- 
tion. Na+ enhances the binding of angiotensin to its 
receptor [36]. It also plays an important role in the 
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action of opiates, although in comparison to the 
cholinergic agents the situation appears to be reversed. 
At low Na ÷ concentrations the binding of opiate 
agonists to their receptors i stronger than that of 
antagonists. At high Na ÷ concentrations the reverse 
holds [37]. In agreement with this is the observation 
that in the hybrid cells the concentration of opiates 
causing a half maximal increase in the level of cyclic 
GMP is much lower at low than at high Na ÷ concen- 
trations [20]. Other explanations for the effect of 
Na ÷ on the hybrids must also be considered. E.g., 
high Na ÷ concentration could increase the constant 
for the binding of cholinergic agonists to their recep- 
tor or could enhance the activity of the guanylate 
cyclase. The report that cholinergic agonists, in 
homogenates of neuroblastoma cells, activate 
adenylate cyclase [38] seems to contradict our 
findings [7]. However, the discrepancy may be 
resolved in the light of the effects of Na + reported 
here, for the adenylate cyclase activities had been 
measured in the absence of or at very low concentra- 
tions ofNa ÷ [38]. 
The seventh aspect of this communication is the 
difference in the action of the 3 cholinergic agents 
used. The highest elevation of the level of cyclic GMP 
was brought about by Carb, which stimulates both 
muscarinic and nicotinic receptors [18] and by TMA 
that is considered a nicotinic agonist [18] ; a compar- 
atively small effect was seen in the presence of the 
muscarinic agonist Pil [18]. At low Na + the concen- 
tration dependency of the action of Pil was running 
inversely to that of  the 2 other agonists. At present 
we do not have an explanation for this phenomenon. 
Thus, on the basis of these results a classification of 
the cholinergic receptor(s) of the hybrid cells as 
nicotinic or muscarinic is not feasible. It is interesting 
to note that in depressing the effect of prostaglandin 
Et the action of cholinergic agents was clearly medi- 
ated by a receptor sensitive only to the muscarinic 
antagonist atropine, but not to nicotinic antagonists 
[7]. A detailed study of the effects of cholinergic 
antagonists i  in progress. 
The eighth aspect is the extremely similar behaviour 
of all cell lines tested. Thus, besides the difference in 
their make-up of neurotransmitter enzymes, the cell 
lines, including the hybrids, have many properties in 
common. One among these properties i the increase 
in the level of cyclic AMP in the presence of prosta- 
glandin E1 [15]. 
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